Back to results
US 6,541,453 B2Granted
Peptide derivatives
AssigneeSyngenta Limited
InventorsKeith Oldham, Philip Neil Edwards, Richard William Arthur Luke, Ronald Cotton
Life of this patent
Estimating the term…
Abstract
Novel peptide derivatives, pharmaceutically acceptable salts thereof and pharmaceutical compositions containing then are useful in treating MHC class II dependent T-cell method autoimmune or inflammatory diseases, such as rheumatoid arthritis.
Claims13
A peptide derivative of the formula
- P-AA1-AA2-AA3-II-AA5-IIIa-AA8-Q
- or a pharmaceutically acceptable salt thereof, wherein
- P is a hydrophobic residue;
- AA1, AA2, AA3, AA5, and AA8 are L-amino acid residues;
- II is a residue of an L-amino acid of formula II
- wherein
- n is an integer 1, 2, 3 or 4;
- X is —NH—CO—, —CC— or —OCO—;
- R1 and R2 are selected from (A), (B) and (C) wherein
- A) is a group of the formula —(CH2)a—CO—N(R3)(R4) in which a is an integer 1 or 2 and R3 and R4 are independently selected from a group —{(CH2)bO}m—Ra in which Ra is methyl or ethyl and m is an integer 1, 2, 3, 4 or 5;
- when m is 1, b is 2 or 3 and when m is 2, 3, 4 or 5, the value of b in each —(CH2)bO— unit is independently selected from 2 and 3;
- (B) is a group of the formula —(CH2)cO(CH2)d—CO—N(R5)(R6) in which c is an integer 2 or 3, d is an integer 1, 2 or 3 and R5 and R6 are independently selected from a group —{(CH2)eO}p—Rb in which Rb is methyl or ethyl and p is an integer 1, 2, 3, 4 or 5;
- when p is 1, e is 2 or 3 and when p is 2, 3, 4 or 5, the value for e in each —(CH2)eO— unit is independently selected from 2 and 3;
- and (C) is a group of the formula —{(CH2)fO}g—R7 in which R7 is methyl or ethyl and g is an integer 1, 2, 3, 4 or 5;
- when g is 1, f is 2 or 3 and when g is 2, 3, 4 or 5, the value for f in each —(CH2)fO— unit is independently selected from 2 and 3;
- IIIa is a group of the formula
- and Q is OH, NH2, NRcRd wherein Rc is selected from (1-4C)alkyl, 2-carbamoylcyclopentyl, 2-pyridylmethyl, 4-carbamoylcyclohexyl, 4-carbamoylcyclohexylmethyl, 3-carbamoylphenyl, 4-carbamoylphenyl, 4-(carbamoylmethyl)phenyl, 4-(carboxymethyl)phenyl, 2-morpholinoethyl and a group of the formula —A1—G1 in which A1 is (3-7C)alkylene or A1 is selected from
- (1) a group of the formula —A2—B2— in which A2 is p-phenylene or 1,4-cyclohexylene and B2 is (1-4C)alkylene or A2 is methylene and B2 is p-phenylene or 1,4-cyclohexylene;
- and
- (2) a group of the formula —A3—B3—C3— in which A3 is methylene, B3 is p-phenylene or 1,4-cyclohexylene and C3 is (1-3C)alkylene;
- and
- G1 is a group of the formula —N═C{N(Rp)2}2 in which each Rp is independently selected from hydrogen, methyl, ethyl and propyl and Rd is hydrogen or (1-4C)alkyl;
- or Q is 1-piperazinyl, 4-methyl-1-piperazinyl, 4-(2-(2-hydroxyethoxy)ethyl)-1-piperazinyl, 4-amidino-1-piperazinyl, 1-piperidyl or 4-substituted-1-piperidyl wherein the 4-substituent is selected from carboxy, carbamoyl, N-(2-aminoethyl)carbamoyl and N-(4-aminobutyl)carbamoyl;
- or Q is a sequence of 1 to 6 amino acid residues or an amide of Q.
21 more elements
Dependencies are inferred from the claim text.